glp-1 compounding news november 2025 Diabetes advocacy group discourages use of compounded drugs Drugmakers battle pharmacies over compounded

Following single administration, the elimination half-life of prototype BPC-157 was less than 30 minutes in both species, indicating rapid systemic clearance

15 Cancers GLP-1s have been investigated for their impact in reducing the risk of obesity-related cancers (OACs) such as colorectal cancer, esophageal, breast, colorectal, endometrial, gallbladder, stomach, kidney, ovarian, pancreatic, and thyroid cancer, as well as hepatocellular carcinoma, meningioma, and multiple myeloma

Pair with beauty tools such as gua sha, lymphatic brush, or dry brush techniques to support circulation and skin vitality

D.JayaramanA.et al (2020c)